At a glance
ClinicalIndex Comparison RecordN/ACompleted· 62 enrolled
Drug / intervention
Currently marketed Hydrophillic Intermittent Catheter +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Consumer Evaluation of Intermittent Catheter Product Modifications
In Brief
A clinical study evaluating Currently marketed Hydrophillic Intermittent Catheter and Test Hydrophilic Intermittent Catheter for Urinary Incontinence. Completed, enrolled 62 participants across 1 site.
Detailed Summary
This study aims to collect feedback from hydrophilic intermittent catheter end-users to assess user acceptance of the test hydrophilic intermittent catheter and generate evidence to support commercial marketing objectives.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Incontinence
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartOct 2020
First PostedNov 2020
Primary CompletionAug 2021
TodayJul 2026
First PostedNov 6, 2020
Enrollment StartOct 14, 2020
Primary CompletionAug 17, 2021
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 5.7 years ago
Interventions
Currently marketed Hydrophillic Intermittent Catheterdevice
Currently marketed Hollister standard with tip hydrophilic intermittent catheter
Test Hydrophilic Intermittent Catheterdevice
Hollister standard with tip hydrophilic intermittent catheter with design enhancements